IRI — Integrated Research Share Price
- AU$75.95m
- AU$45.56m
- AU$83.29m
- 85
- 95
- 50
- 88
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 5.76 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | -12.61% | ||
Dividend Yield (f) | 4.6% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.83 | ||
Price to Tang. Book | 0.83 | ||
Price to Free Cashflow | 7.7 | ||
Price to Sales | 1.07 | ||
EV to EBITDA | 2.51 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 19.35% | ||
Return on Equity | 25.18% | ||
Operating Margin | 25.41% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | AU$m | 110.91 | 78.49 | 62.87 | 69.83 | 83.29 | 72.5 | 77.3 | -3.75% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +9.81 | -69.24 | -91.11 | n/a | n/a | -51.9 | +4.11 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Integrated Research Limited is an Australia-based provider of user experience and performance management solutions for payment transactions and collaborative systems. The Company offers three key solution suites: Collaborate, Transact and Infrastructure - powered by the Prognosis platform. Its Collaborate solution offers enterprise grade performance management, testing solutions and analytics across voice, Web, video and collaboration ecosystems. Its Transact solution includes analyzing transaction data, deploying new technology and ensuring a seamless payments experience to keep its client card, high value and real-time payments business flowing. The Company's infrastructure solution includes access to real-time insight into HPE Non-Stop environments to help manage information technology (IT) performance, spot patterns in data and proactively prevent problems. Its solutions are used by various organizations, such as stock exchanges, banks and telecommunication companies.
Directors
- Peter Lloyd NEC
- John Ruthven CEO
- Peter Adams CFO
- David Purdue SEC
- Allan Brackin NID
- Patricia Myers NID
- James Scott NID
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 3rd, 1988
- Public Since
- December 13th, 2000
- No. of Employees
- 142
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
Australian Stock Exchange - SEATS
- Shares in Issue
- 174,609,000

- Address
- L 9 100 Pacific Hwy, NORTH SYDNEY, 2060
- Web
- https://www.ir.com/
- Phone
- +61 299661066
- Auditors
- Ernst & Young
Upcoming Events for IRI
Similar to IRI
3P Learning
Australian Stock Exchange - SEATS
5G Networks
Australian Stock Exchange - SEATS
8Common
Australian Stock Exchange - SEATS
ActivePort
Australian Stock Exchange - SEATS
Adisyn
Australian Stock Exchange - SEATS
FAQ
As of Today at 21:19 UTC, shares in Integrated Research are trading at AU$0.44. This share price information is delayed by 15 minutes.
Shares in Integrated Research last closed at AU$0.44 and the price had moved by +6.1% over the past 365 days. In terms of relative price strength the Integrated Research share price has outperformed the ASX All Ordinaries Index by +2.25% over the past year.
The overall consensus recommendation for Integrated Research is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Integrated Research dividend yield is 4.6% based on the trailing twelve month period.
Last year, Integrated Research paid a total dividend of AU$0.02, and it currently has a trailing dividend yield of 4.6%. We do not have any data on when Integrated Research is to next pay dividends.
We do not have data on when Integrated Research is to next pay dividends. The historic dividend yield on Integrated Research shares is currently 4.6%.
To buy shares in Integrated Research you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.44, shares in Integrated Research had a market capitalisation of AU$75.95m.
Here are the trading details for Integrated Research:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: IRI
Based on an overall assessment of its quality, value and momentum Integrated Research is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Integrated Research is AU$0.80. That is 83.91% above the last closing price of AU$0.44.
Analysts covering Integrated Research currently have a consensus Earnings Per Share (EPS) forecast of AU$0.07 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Integrated Research. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -28.97%.
As of the last closing price of AU$0.44, shares in Integrated Research were trading -22.08% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Integrated Research PE ratio based on its reported earnings over the past 12 months is 5.76. The shares last closed at AU$0.44.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Integrated Research's management team is headed by:
- Peter Lloyd - NEC
- John Ruthven - CEO
- Peter Adams - CFO
- David Purdue - SEC
- Allan Brackin - NID
- Patricia Myers - NID
- James Scott - NID